跳至主要内容
临床试验/NCT00315913
NCT00315913撤回2 期

Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor

University of California, Irvine1 个研究点 分布在 1 个国家开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1

研究概览

简要总结

The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.

详细描述

This trial was designed to test if propranolo can reduce the c section rate for dysfuctional labor. Due to stringent inclution and exclusion criteria and low enrollment the study was closed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Must be term pregnancy (> 37 weeks)
  • Vertex presentation
  • Active labor (4-5 centimeters dilated)

排除标准

  • Heart disease
  • Currently taking propranolol
  • Contraindications to labor or vaginal delivery
  • Multiple gestations
  • Chorioamnionitis

研究组 & 干预措施

IV Propranolol

Experimental

IV dose propranolol

干预措施: Propranolol (Drug)

IV Placebo

Placebo Comparator

IV Placebo of saline solution equal to propranolol in volume

干预措施: IV Placebo (Other)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deborah A. Wing

Professor and MFM Division Director

University of California, Irvine

研究点 (1)

Loading locations...

相似试验